Clorox Co

CLX has experienced a clear capitulation flush indicating forced selling exhaustion and potential for a reflex rally. Long-term trend remains bearish under a declining 200-day SMA, but extreme oversold conditions and mean-reversion eligibility favor a medium-term bullish asymmetry. Price is extended well below all major EMAs, and short-term timing lacks clear stabilization or acceptance. Defer new entries and look to buy on constructive follow-through or pullback absorption into the EMAs near the capitulation low.

• ↑Dividend at $1.25/share yields 1.21%, attractive for income investors
• ↑Q4 FY26 revenue of $1.95B beat consensus by 2.2%
• ↓Q4 EPS fell 42% YoY to $1.66, base EPS halved to $1.34